ICCM
Icecure MedicalNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$7.52M
P/E Ratio
—
EPS
$-7.20
Beta
1.49
52W High
$42.00
52W Low
$2.39
50-Day MA
$7.70
200-Day MA
$18.58
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Icecure Medical
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets. The company is headquartered in Caesarea, Israel.
Fundamentals
| Revenue (TTM) | $3.56M |
| Gross Profit (TTM) | $1.30M |
| EBITDA | $-15.41M |
| Operating Margin | -466.20% |
| Return on Equity | -217.20% |
| Return on Assets | -80.30% |
| Revenue/Share (TTM) | $1.58 |
| Book Value | $3.14 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | 2.11 |
| EV/Revenue | 0.628 |
| EV/EBITDA | -2.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 25.70% |
| Shares Outstanding | $2.81M |
| Float | $1.48M |
| % Insiders | 39.94% |
| % Institutions | 3.86% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Analyst Ratings
Consensus ($44.50 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026